58 related articles for article (PubMed ID: 23581859)
1. MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease.
Hata H; Abe R; Hoshina D; Saito N; Homma E; Aoyagi S; Shimizu H
J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):727-32. PubMed ID: 23581859
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of glucose transporter isoform 1 in invasive and metastatic extramammary Paget's disease.
Matsumoto M; Rokunohe D; Sasaki T; Matsuzaki Y; Nakano H; Mizukami H; Akasaka E; Sawamura D
Exp Ther Med; 2024 May; 27(5):228. PubMed ID: 38596658
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical and clinicopathological study regarding nardilysin on extramammary Paget's disease.
Yamaguchi A; Takahashi T; Kato T; Tanaka T; Nishi E; Fujimoto N
Arch Dermatol Res; 2023 Sep; 315(7):1979-1987. PubMed ID: 36867223
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of androgen receptor expression in extramammary Paget disease: An analysis of 92 patients.
Kuramoto J; Kobayashi K; Hirai I; Nakamura Y; Funakoshi T; Kanai Y
Pathol Res Pract; 2023 Sep; 249():154775. PubMed ID: 37634315
[TBL] [Abstract][Full Text] [Related]
5. NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
Tanaka Y; Ito T; Murata M; Tanegashima K; Kaku-Ito Y; Nakahara T
Exp Dermatol; 2024 Mar; 33(3):e15049. PubMed ID: 38509717
[TBL] [Abstract][Full Text] [Related]
6. Recent treatment and prognosis in 643 patients with extramammary Paget's disease.
Hatta N; Ogata D; Asai J; Maekawa T; Ito T; Takenouchi T; Kiniwa Y; Miyashita A; Miyagawa T; Muto I; Yamamoto Y; Nagano T; Kiyohara Y; Nakano E; Ohe S; Yamaguchi B; Fukuyama M; Matsuya T; Tsutsumida A; Namikawa K; Yamazaki N
Exp Dermatol; 2024 Feb; 33(2):e15030. PubMed ID: 38375900
[TBL] [Abstract][Full Text] [Related]
7. Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease.
Kang Z; Jiang L; Chen D; Yan G; Zhang G; Lai Y; Zeng Q; Wang X
Skin Res Technol; 2023 Oct; 29(10):e13497. PubMed ID: 37881057
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of heat shock protein 90 through the downregulation of miR-9-5p in extramammary Paget's disease.
Ohnuma T; Mijiddorj MT; Kajihara I; Sawamura S; Sakamoto R; Maeda-Otsuka S; Yamada-Kanazawa S; Makino K; Aoi J; Masuguchi S; Fukushima S
J Dermatol; 2023 Sep; 50(9):1216-1221. PubMed ID: 37208828
[TBL] [Abstract][Full Text] [Related]
9. FOXM1: a new therapeutic target of extramammary Paget disease.
Ito T; Tanaka Y; Kaku-Ito Y; Oda Y; Nakahara T
Sci Rep; 2024 Feb; 14(1):4048. PubMed ID: 38374400
[TBL] [Abstract][Full Text] [Related]
10. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target.
Nakamura Y; Mizukami H; Tanese K; Fusumae T; Hirai I; Amagai M; Takamatsu R; Nakamura K; Nishihara H; Takimoto T; Ueno M; Saya H; Funakoshi T
J Dermatol Sci; 2023 Oct; 112(1):23-30. PubMed ID: 37661472
[TBL] [Abstract][Full Text] [Related]
11. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
[TBL] [Abstract][Full Text] [Related]
12. CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.
Hashimoto H; Kaku-Ito Y; Oda Y; Ito T
Front Oncol; 2021; 11():710378. PubMed ID: 34395284
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonography for the Diagnosis and Follow-Up of Extramammary Paget Disease (EMPD): A Review.
Just-Sarobé M; Sánchez-Puigdollers A; Mohino-Farré N; Martin-Callizo C; Pujol-Montcusí JA; Pastor-Jane L
J Ultrasound Med; 2024 Mar; 43(3):423-427. PubMed ID: 38054379
[TBL] [Abstract][Full Text] [Related]
14. The utility of p63, CK7, and CAM5.2 staining in differentiating pagetoid intraepidermal carcinomas.
Wieland R; Adhikari P; North J
J Cutan Pathol; 2023 Dec; 50(12):1110-1115. PubMed ID: 37203381
[TBL] [Abstract][Full Text] [Related]
15. Loss of p16 Immunoexpression and Deletions of CDKN2A in the Progression of Extramammary Paget Disease: An Immunohistochemical and Genetic Study of 24 Invasive/Metastatic Cases.
Hiraki T; Oishi T; Yoshikawa S; Honma K; Ohe S; Isei T; Kukita Y; Takai T; Shimada K; Takei Y; Goto K
Am J Dermatopathol; 2024 Apr; ():. PubMed ID: 38648029
[TBL] [Abstract][Full Text] [Related]
16. Untargeted metabolomics yields insight into extramammary Paget's disease mechanisms.
Jiang L; Xu X; Yan G; Wu Y; Xi N; Lai Y; Zhang G; Liu Y
Front Oncol; 2024; 14():1319819. PubMed ID: 38347841
[TBL] [Abstract][Full Text] [Related]
17. Trousseau Syndrome in a Case of Extramammary Paget's Disease.
Fujimoto M; Ishitsuka Y; Tanemura A; Nojima S; Fujimoto M
Acta Derm Venereol; 2023 Sep; 103():adv9405. PubMed ID: 37766658
[No Abstract] [Full Text] [Related]
18. Cell origin and genome profile difference of penoscrotum invasive extramammary Paget disease compared with its
Rao Y; Zhu J; Zheng H; Ren Y; Ji T
Front Oncol; 2022; 12():972047. PubMed ID: 36091120
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome sequencing reveals a lncRNA-mRNA interaction network in extramammary Paget's disease.
Zheng DC; Shen YT; Wei ZW; Wan X; Xie MK; Yao HJ; Wang Z
BMC Med Genomics; 2021 Dec; 14(1):291. PubMed ID: 34895219
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
